Quick Takeaways
- VANGUARD GROUP INC filed SCHEDULE 13G/A for Cogent Biosciences Inc Common Stock (COGT).
- Disclosed ownership: 7.5%.
- Date of event: 31 Dec 2025.
VANGUARD GROUP INC - 31 Dec 2025 SCHEDULE 13G/A Report for Cogent Biosciences Inc Common Stock (COGT)
- Filing Manager
- VANGUARD GROUP INC
- Reporting Manager
- The Vanguard Group
- Security
- Cogent Biosciences Inc Common Stock
- Symbol
- COGT
- Shares outstanding
- 153,524,347 shares
- Disclosed Ownership
- 11,514,326 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Jan 2026, 13:26:34 UTC
- Date of event
- 31 Dec 2025
- Next filing
- 26 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"VANGUARD GROUP INC disclosed 7.5% ownership in Cogent Biosciences Inc Common Stock (COGT) on 31 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Jan 2026, 13:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| The Vanguard Group | 7.5% | 11,514,326 | 0 | 1,168,983 | Ashley Grim | Head of Global Fund Administration |